CCR9 blocking peptide product blog
Tags: Blocking Peptide; CCR9; CCR9 blocking peptide;
The CCR9 ccr9 (Catalog #MBS9220246) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The CCR9 ccr9 product has the following accession number(s) (GI #114152781) (NCBI Accession #P51686.2) (Uniprot Accession #P51686). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Receptor for chemokine SCYA25/TECK. Subsequently transduces a signal by increasing the intracellular calcium ions level. Alternative coreceptor with CD4 for HIV-1 infection.
Cellular Location: Cell membrane; Multi-pass membrane protein. Tissue Location: Highly expressed in the thymus and low in lymph nodes and spleen. The following patways have been known to be associated with this gene. CCR9 also interacts with the following gene(s): CCL19, CCL20, CCL21, CCL25, CCL27, CCL28, CXCL11, CXCL12, CXCL13. Intestine, Kidney, Mixed, Stomach, Thymus tissues are correlated with this protein. Atrophy, Disease Models, Animal, Drug-Related Side Effects and Adverse Reactions, Fibrosis, Hypersensitivity, Inflammation, Liver Diseases, Liver Neoplasms, Necrosis, Neoplasms, Experimental are some of the diseases may be linked to CCR9 Antibody (C-term) Blocking peptide.